Month: January 2026

Fatality at Coringa Mine Serabi Gold plc (“Serabi” or the “Company”) (AIM:SRB, TSX:SBI, OTCQX:SRBIF), the Brazilian focused gold mining and development company, regrets to announce an accident occurred resulting in a fatality at its Coringa underground operation on 25 January 2026. The accident was related to mining activity at a production face. No other personnel were injured in the incident. The Company has notified the relevant authorities, including the police, and are providing all necessary assistance for the enquiries into the incident. The involvement of the Brazilian authorities means that investigations into the circumstances of the accident remain ongoing. Production in the area of the incident is expected to be resumed within a few days once the authorities have completed their enquiries, but mining operations are otherwise...

EMERYVILLE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) — Grocery Outlet Holding Corp. (NASDAQ: GO) (“Grocery Outlet” or the “Company”), a high-growth, extreme value retailer of quality, name-brand consumables and fresh products, today announced that it raised enough funds to provide two million meals* to people facing hunger through its holiday campaign with Feeding America®, the nation’s largest hunger-relief organization. The initiative, which ran from mid-November through December 31, was part of Grocery Outlet’s ongoing commitment to fight hunger and support the local communities it operates in. During the campaign, customers were invited to donate at checkout, and store operators were able to choose which local food bank or community organization they wished to support. Grocery Outlet also matched a portion...

Topline data expected in 1Q 2028 Phase 2 bipolar depression trial initiation follows positive Phase 2 results in acute schizophrenia NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases, today announced the initiation of a Phase 2 trial evaluating the efficacy and safety of LB-102 in patients with bipolar depression. LB-102, a novel, once-daily, oral investigational small molecule, is a potent and selective antagonist of D2, D3, and 5HT7 receptors that is being advanced as a potential first benzamide antipsychotic in the U.S. for the treatment of neuropsychiatric disorders. “Our year is off to a strong start and the initiation...

The Vista West Community Park by LGI HomesThe new park at Vista West features a pickleball and basketball courts, a splashpad, playground, zip line, soccer field, baseball backstop, dog park, shaded gazebo with picnic tables and barbecue grills, and scenic walking trails.FORT WORTH, Texas, Jan. 26, 2026 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) is excited to announce the opening of a brand-new community park at Vista West, a growing residential neighborhood in Fort Worth, Texas. Spanning 13.5 acres, the park was thoughtfully designed to enhance daily life for residents by offering inviting outdoor spaces for recreation, relaxation, and connection. Located at the heart of the community, the park serves as a central gathering place where residents of all ages can enjoy a wide range of amenities. Features include...

Q4 Results Expected to Generate 3rd Consecutive Quarter of Positive Operating Cash Flow GRAPEVINE, Texas, Jan. 26, 2026 (GLOBE NEWSWIRE) — Solo Brands, Inc. (NYSE: SBDS) (“Solo Brands” or “the Company”) a leading portfolio of lifestyle brands (Solo Stove, Chubbies, Isle and Oru) that are redefining the outdoor and apparel industries, announces preliminary unaudited selective financial information for the fourth quarter ended December 31, 2025. The Company also plans to release its full financial results on Thursday, March 19, 2026, pre-market, and then host a conference call at 9:00 a.m. ET to discuss Solo Brands’ strategy and financial results on the same day. “Our fourth quarter results demonstrate the impact of decisive cost restructuring actions alongside solid execution on new product launches. Preliminary Fiscal 2025...

WESTLAKE VILLAGE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that on January 23, 2026, the Company and Kowa Pharmaceuticals America, Inc. mutually agreed to terminate their promotion agreement. The agreement covered sales and promotion of ZORYVE® (roflumilast) by Kowa to primary care physicians and pediatricians in the United States. Following the termination, Arcutis plans to assume responsibility for sales and promotion of ZORYVE in the pediatric and primary care settings. The Company is finalizing its plans for promotion to these clinicians and will provide further updates during the Q4 earnings call on February 25, 2026. This initiative is distinct from...

BELO HORIZONTE Brazil and SINGAPORE, Jan. 26, 2026 (GLOBE NEWSWIRE) — Verde AgriTech Ltd. (TSX: NPK | OTCQX: VNPKF) (“Verde” or the “Company”) is pleased to report additional assay results from its ongoing drilling program at the Minas Americas Global Alliance Project (the “Project”) in Minas Gerais, Brazil. “Our first drilling target (PT-34) is already delivering the combination that matters in rare earth discoveries: shallow thickness, repeated high grades, and a magnet‑rich rare earth basket,” said Cristiano Veloso, Founder and CEO of Verde. “With significant intercepts now extending across PT‑34 and multiple holes finishing in mineralization, we are prioritizing scale capture. Given the strength of results so far, the Board has approved expanding the resource definition footprint and drilling additional metres to better outline...

LOWELL, Mass., Jan. 26, 2026 (GLOBE NEWSWIRE) — MACOM Technology Solutions Holdings, Inc. (“MACOM”) (NASDAQ: MTSI), a leading supplier of semiconductor products, today announced the promotions of two senior leaders within the organization to the Senior Vice President level. These promotions further strengthen and expand MACOM’s management team, with a focus on executing strategic corporate initiatives to grow and better serve its diverse customer base, as well developing advanced semiconductor technologies. Mr. Stephen Ferranti promoted to Senior Vice President Corporate Development and Investor Relations. Mr. Ferranti joined MACOM in 2016 and has recently served as MACOM’s Vice President, Corporate Development and Investor Relations. Mr. Ferranti brings broad-based experience in corporate development, marketing and growth strategies,...

NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE:VNO) announced today that its 53% owned joint venture has completed a $250 million refinancing of 7 West 34th Street, a 477,000 square foot Class A Manhattan office building. Amazon leases all of the office space at the property. The non-recourse, five-year interest only loan matures in February 2031 and has a fixed rate of 5.79%. The joint venture paid down by $50 million the prior $300 million loan that was fully recourse to Vornado, bore interest at 3.65% and was scheduled to mature in June 2026. Vornado Realty Trust is a fully-integrated equity real estate investment trust. CONTACT Thomas J. Sanelli(212) 894-7000 Certain statements contained herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act...